These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
705 related items for PubMed ID: 17167720
1. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary? Yerushalmi R, Sulkes A, Mishaeli M, Neumann A, Dinerman M, Sulkes J, Rizel S, Yarom N, Gutman H, Fenig E. Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720 [Abstract] [Full Text] [Related]
4. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history. Hiramatsu H, Bornstein BA, Recht A, Schnitt SJ, Baum JK, Connolly JL, Duda RB, Guidi AJ, Kaelin CM, Silver EB, Harris JR. Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455 [Abstract] [Full Text] [Related]
6. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Solin LJ, Fourquet A, Vicini FA, Haffty B, Taylor M, McCormick B, McNeese M, Pierce LJ, Landmann C, Olivotto IA, Borger J, de La Rochefordiere A, Schultz DJ. Cancer; 2001 Mar 15; 91(6):1090-7. PubMed ID: 11267953 [Abstract] [Full Text] [Related]
7. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Reitsamer R, Peintinger F, Kopp M, Menzel C, Kogelnik HD, Sedlmayer F. Strahlenther Onkol; 2004 Jan 15; 180(1):38-44. PubMed ID: 14704843 [Abstract] [Full Text] [Related]
9. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience. Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R. Breast J; 2005 Jan 15; 11(4):242-7. PubMed ID: 15982389 [Abstract] [Full Text] [Related]
11. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Jeruss JS, Vicini FA, Beitsch PD, Haffty BG, Quiet CA, Zannis VJ, Keleher AJ, Garcia DM, Snider HC, Gittleman MA, Whitacre E, Whitworth PW, Fine RE, Arrambide S, Kuerer HM. Ann Surg Oncol; 2006 Jul 15; 13(7):967-76. PubMed ID: 16788759 [Abstract] [Full Text] [Related]
12. Conservative surgery and radiation therapy for intraductal carcinoma of the breast. Lewin AA, Cohen A, Abitbol AA, Schwade JG, Osman D, DerHagopian R, Ostroski J, Marcial-Vega V, Houdek P, Gould E. J Fla Med Assoc; 1992 Nov 15; 79(11):762-5. PubMed ID: 1336028 [Abstract] [Full Text] [Related]
15. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience. Trombetta M, Julian T, Bhandari T, Werts ED, Miften M, Parda D. Brachytherapy; 2008 Nov 15; 7(1):29-36. PubMed ID: 18201940 [Abstract] [Full Text] [Related]
16. Influence of local treatment on the recurrence rate of ductal carcinoma in situ. Warneke J, Grossklaus D, Davis J, Stea B, Bebb G, Taylor C, Hastings R, Villar H. J Am Coll Surg; 1995 Jun 15; 180(6):683-8. PubMed ID: 7773481 [Abstract] [Full Text] [Related]
17. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery. Boland GP, Chan KC, Knox WF, Roberts SA, Bundred NJ. Br J Surg; 2003 Apr 15; 90(4):426-32. PubMed ID: 12673743 [Abstract] [Full Text] [Related]